(Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the publication of data ...
Gastroenterologists diagnose irritable bowel syndrome (IBS) more often than any other disorder. 1 The main symptoms are chronic or recurrent bloating, discomfort, or pain in the abdomen and abnormal ...
Preclinical studies find that an innovative bilayered capsule can overcome current challenges for delivering drugs to the colon. The findings suggest a new solution for relieving abdominal pain ...
Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Irritable bowel syndrome with ...
Tenapanor (Ibsrela) is an FDA-approved medication designed to help manage irritable bowel syndrome with constipation (IBS-C) when other treatments aren’t effective. The medication increases water ...
LOUISVILLE, Ken., April 1, 2019 /PRNewswire/ -- US WorldMeds has announced that Sloan Pharma, S.a.r.l., a subsidiary of US WorldMeds Holdings, LLC, has received approval from the U.S. Food and Drug ...
Some people cut out so many foods, for fear of triggering gut symptoms, that it makes their digestive problems worse, experts say ...
Bowel problems which may end up in cancer anywhere in the digestive tract appear to be in vogue. Many people, like a joke or child’s play, do not give them deserved attention until the doctor ...
When you live with irritable bowel syndrome (IBS), avoiding foods that trigger symptoms is part of daily life. Coffee has a reputation as a bowel stimulant, but the link between coffee and IBS isn’t ...
NEW YORK (Reuters Health) - Long-term constipation doesn't raise risk for colon and rectal cancers according to a new analysis of the existing evidence. Past studies had suggested a possible ...
Patients suffering from irritable bowel syndrome with constipation (IBS-C) have long needed an upgrade in treatment. Rapid-release, cramp-inducing doses of chenodeoxycholic acid (CDC) have previously ...